ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® GU 2024 Insights: "EV-302 study - Enfortumab Vedotin in Combination With Pembrolizumab for 1L la/mUC"
By
ecancer
FEATURING
Michiel Simon Van Der Heijden
By
ecancer
FEATURING
Michiel Simon Van Der Heijden
Comments 0
Login to view comments.
Click here to Login
